Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery

Nanomedicine (Lond). 2019 Oct;14(19):2549-2565. doi: 10.2217/nnm-2019-0217. Epub 2019 Jul 4.

Abstract

Aim: O-carboxymethyl chitosan/perfluorohexane nanodroplets (O-CS NDs) and doxorubicin-loading O-carboxymethyl chitosan nanodroplets were synthesized and functionally tested as drug delivery system in vitro. Materials & methods: The characteristics, charge conversion, stability, cytotoxicity, ultrasound imaging ability, interaction with tumor cells of the nanodroplets and eradication on tumor cells of the doxorubicin-loaded nanodroplets were investigated. Results: O-CS NDs (below 200 nm) achieved higher tumor cellular associations at acidic pH, with great serum stability, pH-dependent charge conversion and good ultrasound imaging ability. Doxorubicin-loading O-carboxymethyl chitosan nanodroplets exhibited strong cytotoxicity on PC-3 cells with ultrasound exposure. Conclusion: These stable, safe and smart O-CS NDs may be a promising approach to improve cell interaction efficiency as an ultrasound imaging and cancer-targeting drug delivery system.

Keywords: ADV; O-carboxymethyl chitosan; acoustic droplet vaporization; charge-conversion; nanodroplets; ultrasound.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Chitosan / analogs & derivatives*
  • Chitosan / chemistry
  • Chitosan / pharmacology
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology
  • Drug Delivery Systems*
  • Humans
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Particle Size
  • Ultrasonography

Substances

  • O-carboxymethylchitosan
  • Doxorubicin
  • Chitosan